Paul R. Hansen is Director at Vyant Bio, Inc. (VYNT). They have made 1 open-market trade across 1 company since 2021, most recently 2023-01-17.
CIK 0001850324
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $47K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VYNT | 159,778 | $108K |
Shares reported on the most recent Form 4, priced at the 2023-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYNT | BUY | 2021-08-19 | 2021-08-23 | $2.35 | $47K | +12.7% | -4.1% | -17.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.